Stratim Capital buys into Linden Lab

Stratim Capital, an institutionally funded secondary-market private-equity firm, is reported to have bought into Linden Lab by buying out most of the holdings of one of the other investors. "We bought almost the entire position of an existing shareholder," said Stratim managing partner, Zach Abrams. Which shareholder, and how much was paid remains a mystery. A previous sale of less than a 5% share in Linden Lab sold for approximately half a billion US Dollars in 2007.

There is no primary private-equity market for Linden Lab. The company does not seek investors, and by all accounts is making enough money that it doesn't need additional investment capital. There's also no sign of an IPO on the horizon, nor indeed, any compelling reason why the Lab should want to have one.